Peter Ljubenkov, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology (NCT05184569) | Peter Ljubenkov, MD | 2022-04-14 |
Track Peter Ljubenkov, MD automatically
Every clearance here is in the API, with alerts when new ones post.